SynthesisFrontiers in oncology2022

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer.

Yuexiao Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.